CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,150,134 | +136.8% | 744,816 | +43.5% | 0.01% | +133.3% |
Q2 2023 | $9,353,979 | +29.6% | 519,109 | +15.5% | 0.00% | +50.0% |
Q1 2023 | $7,220,275 | +77445.6% | 449,605 | -11.6% | 0.00% | -33.3% |
Q4 2022 | $9,311 | -99.9% | 508,848 | -5.1% | 0.00% | -25.0% |
Q3 2022 | $10,528,000 | +1.9% | 536,070 | -3.2% | 0.00% | 0.0% |
Q2 2022 | $10,329,000 | -3.8% | 553,871 | +13.2% | 0.00% | +33.3% |
Q1 2022 | $10,736,000 | +9.4% | 489,357 | +41.7% | 0.00% | 0.0% |
Q4 2021 | $9,814,000 | +49.7% | 345,444 | +11.0% | 0.00% | +50.0% |
Q3 2021 | $6,554,000 | +87.6% | 311,344 | +68.0% | 0.00% | +100.0% |
Q2 2021 | $3,493,000 | +247.9% | 185,293 | +181.9% | 0.00% | – |
Q1 2021 | $1,004,000 | +197.9% | 65,720 | +175.0% | 0.00% | – |
Q4 2020 | $337,000 | – | 23,895 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 820,720 | $17,276,000 | 7.15% |
5AM Venture Management, LLC | 1,362,286 | $28,676,000 | 5.82% |
Bain Capital Life Sciences Investors, LLC | 1,679,701 | $35,358,000 | 2.19% |
Opaleye Management Inc. | 402,113 | $8,464,000 | 1.58% |
FRAZIER MANAGEMENT LLC | 851,306 | $17,920,000 | 1.43% |
Perceptive Advisors | 3,963,517 | $83,432,000 | 1.21% |
Altium Capital Management LP | 193,000 | $4,063,000 | 1.07% |
MPM BioImpact LLC | 298,392 | $6,281,000 | 0.97% |
SPHERA FUNDS MANAGEMENT LTD. | 548,643 | $11,549,000 | 0.97% |
Ghost Tree Capital, LLC | 150,000 | $3,158,000 | 0.92% |